C(OC(=O)[CH2:5][CH2:6][NH:7][C:8]1[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=1)C.[CH2:15]=[C:16]1[O:20][C:18](=[O:19])[CH2:17]1.[CH3:21][O-:22].[Na+]>C1C=CC=CC=1.CO>[C:8]1([N:7]2[CH2:6][CH2:5][C:21](=[O:22])[CH:17]([C:16](=[O:20])[CH3:15])[C:18]2=[O:19])[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=1N-Phenyl-β-alanine ethyl ester (24,25 g) is dissolved in benzene (60 ml), and thereto is added dropwise diketene (12 ml) at 70° C. The mixture is refluxed overnight. The mixture is distilled to remove the solvent to give crude N-phenyl-N-methoxycarbonylmethylcarbonyl-β-alanine ethyl ester (37.23 g). Said crude compound is dissolved in methanol (70 ml), and the mixture is added dropwise to a solution of sodium methoxide (prepared from 3.90 g of sodium) in methanol (70 ml) at 50° C. The mixture is stirred at 50° C. for 2 hours, and distilled to remove the solvent. The residue is dissolved in water, and the aqueous solution is extracted with ethyl acetate. The aqueous layer is neutralized with 10% HCl, and extracted with ethyl acetate. The extract is washed with a saturated sodium chloride solution, dried and then distilled to remove the solvent. The residue is purified by silica gel column chromatography (solvent, ethyl acetate:n-hexane=1:2) to give 1-phenyl-3-acetyl-2,4-dioxopiperidine (23.87 g, 81.6%) as oil.